Skip to content

13F-HR filed by RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2016-09-30, filed 2016-11-14, with 30 holding rows worth $969,369,000.

Accession
0001144204-16-134325
Filed
2016-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2016

A holdings report, 31 entries on the cover page, a total value of $969,369,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $969,369,000 with VALUE read as thousands by filing date, 13F file number 028-12884. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
WAVE LIFE SCIENCES LTD SHSY95308105Stock7,088,651$230,168,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM12,033,220$97,469,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR3,681,491$73,998,000thousands by filing date
AVEXIS INC05366U100COM1,732,274$71,387,000thousands by filing date
AXOVANT SCIENCES LTDG0750W104COM5,000,000$70,000,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM3,664,154$62,950,000thousands by filing date
ARDELYX INC039697107COM3,266,045$42,263,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock1,547,152$39,623,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock4,631,114$35,845,000thousands by filing date
ZOGENIX INC.98978L204Common Stock2,656,166$31,451,000thousands by filing date
AQUINOX PHARMACEUTICALS INC03842B101COM2,191,977$29,285,000thousands by filing date
AIMMUNE THERAPEUTICS INC.00900T107Common Stock1,292,940$19,394,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS1,820,138$16,854,000thousands by filing date
PROTAGONIST THERAPEUTICS74366E102COM754,411$15,941,000thousands by filing date
PROTEON THERAPEUTICS INC74371L109COM1,626,931$15,179,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM2,428,571$14,280,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock2,989,795$13,185,000thousands by filing date
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD2,501,667$13,059,000thousands by filing date
AUDENTES THERAPEUTICS INC.05070R104Common Stock707,426$12,599,000thousands by filing date
DIMENSION THERAPEUTICS INC25433V105COM1,548,033$12,369,000thousands by filing date
ACCELERON PHARMA INC00434H108COM318,565$11,529,000thousands by filing date
ARROWHEAD PHARMACEUTICALS IN04280A100COM1,525,424$11,212,000thousands by filing date
TENAX THERAPEUTICS INC88032L100COM2,389,700$5,532,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR170,000$5,238,000thousands by filing date
Alcobra LtdM2239P109SHS2,044,756$5,051,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM354,200$4,743,000thousands by filing date
SANGAMO THERAPEUTICS INC800677106COM899,438$4,164,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM336,134$2,155,000thousands by filing date
ARCA BIOPHARMA INC00211Y407COM PAR521,606$1,476,000thousands by filing date
AKARI THERAPEUTICS PLC00972G108ADR114,039$970,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001144204-16-134325this filing2016-11-14acceptance time not in the bulk data set